DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
Issue 04 ·
Volume 39 ·
October 2018
DOI: 10.1055/s-011-51134
From the Editor’s Desk
Editorial Commentary
Original Article
493
Noronha, Vanita;
Pandey, Avinash;
Patil, Vijay;
Joshi, Amit;
Choughule, Anuradha Bharat;
Bhattacharjee, Atanu;
Kumar, Rajiv;
Goud, Supriya;
More, Sucheta;
Ramaswamy, Anant;
Karpe, Ashay;
Pande, Nikhil;
Chandrasekharan, Arun;
Goel, Alok;
Talreja, Vikas;
Mahajan, Abhishek;
Janu, Amit;
Purandare, Nilendu;
Prabhash, Kumar:
Tyrosine Kinase Inhibitor versus Physician Choice Chemotherapy in Second-Line Epidermal Growth Factor Receptor Mutation Non-Small Cell Lung Cancer: Post hoc Analysis of Randomized Control Trial
Review Article
503
Agarwal, Mohan B;
Malhotra, Hemant;
Chakarborti, Prantar;
Varma, Neelam;
Mathews, Vikram;
Bhattacharyya, Jina;
Seth, Tulika;
Gyathri, K;
Menon, Hari;
Subramanian, P G;
Sharma, Ajay K;
Bhattacharyya, Maitreyee;
Mehta, Jay;
Shah, Sandeep;
Gogoi, P K;
Nair, Reena;
Agarwal, Usha;
Varma, Subhash;
Prasad, S V V S;
Mishra, Deepak K:
Revised Myeloproliferative Neoplasms Working Group Consensus Recommendations for Diagnosis and Management of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocythemia
Practitioner Section
Case Report
Letters to Editor